EVHEvolent Health, Inc.

$4.80-41% 1Y

Is the business good?

Watch

Margins compressing. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 3 without data
Margin direction, 3 years−21.7 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is EVH?

Evolent Health, Inc. earns −27% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−27%

Return on invested capital · cost of capital 9.0% · 36 points below what the capital costs: growth destroys value

Operating margin
−20%

Operating margin · Health Information Services median 2.8% · 12 months to Q2 2026

Share count, year on year
−2.9%

Share count, year on year · bought back, each share owns more of the company

Gross margin
17%

Gross margin

Operating margin by fiscal year
YearOperating margin
FY2020−28%
FY2021−4.7%
FY20220.27%
FY2023−3.6%
FY2024−1.6%
FY2025−22%
Details›
Gross margin12 months to Q2 2026
17%
Operating margin12 months to Q2 2026
−20%
Net margin12 months to Q2 2026
−24%
Revenue, trailing twelve months
$2.10B
Net income, trailing twelve months
−$505M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−27%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

Customers and suppliers

Who buys from EVH and who it buys from, as the companies report it.

26%of revenue comes from Molina Healthcare, Inc., the largest of 4 disclosed customers
Customerswho buys
Supplierswho it buys from

None disclosed.

A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; EVH’s own figures are from its FY2025 10-K. Smaller customers and suppliers go unreported.